U.S. Physical Therapy (NYSE:USPH) Rating Lowered to Sell at StockNews.com

U.S. Physical Therapy (NYSE:USPH - Get Free Report) was downgraded by stock analysts at StockNews.com from a "hold" rating to a "sell" rating in a research report issued on Friday.

A number of other equities research analysts have also recently commented on USPH. Citizens Jmp raised shares of U.S. Physical Therapy to a "strong-buy" rating in a report on Monday, December 16th. Barrington Research cut their price objective on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating for the company in a research report on Friday. William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a research note on Thursday, February 27th. Bank of America upgraded shares of U.S. Physical Therapy from a "neutral" rating to a "buy" rating and raised their price objective for the company from $100.00 to $115.00 in a research report on Monday, December 16th. Finally, JPMorgan Chase & Co. boosted their target price on U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an "overweight" rating in a research report on Tuesday, December 3rd. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $111.50.

Remove Ads

U.S. Physical Therapy Stock Performance

Shares of U.S. Physical Therapy stock traded down $0.18 on Friday, hitting $79.46. The stock had a trading volume of 112,622 shares, compared to its average volume of 101,701. The company's 50 day moving average price is $87.99 and its 200 day moving average price is $87.62. The stock has a market cap of $1.20 billion, a price-to-earnings ratio of 84.53, a P/E/G ratio of 3.54 and a beta of 1.48. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.27. U.S. Physical Therapy has a 52-week low of $76.18 and a 52-week high of $113.63.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The company reported $0.65 earnings per share for the quarter, missing the consensus estimate of $0.69 by ($0.04). The firm had revenue of $180.45 million during the quarter, compared to analyst estimates of $173.10 million. U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. On average, research analysts anticipate that U.S. Physical Therapy will post 2.67 EPS for the current year.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 516 shares of the business's stock in a transaction on Monday, December 9th. The stock was sold at an average price of $96.25, for a total transaction of $49,665.00. Following the sale, the chief financial officer now directly owns 20,469 shares in the company, valued at approximately $1,970,141.25. The trade was a 2.46 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On U.S. Physical Therapy

Several institutional investors and hedge funds have recently made changes to their positions in the business. CBIZ Investment Advisory Services LLC raised its position in U.S. Physical Therapy by 59.8% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock worth $29,000 after acquiring an additional 122 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of U.S. Physical Therapy during the 4th quarter worth approximately $39,000. Venturi Wealth Management LLC increased its stake in shares of U.S. Physical Therapy by 3,200.0% during the 4th quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock worth $64,000 after purchasing an additional 704 shares in the last quarter. KBC Group NV raised its position in shares of U.S. Physical Therapy by 68.6% during the 3rd quarter. KBC Group NV now owns 774 shares of the company's stock worth $66,000 after purchasing an additional 315 shares during the last quarter. Finally, Lazard Asset Management LLC purchased a new stake in U.S. Physical Therapy in the 4th quarter valued at approximately $84,000.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.